We are live on ! Find out more
GRDN

Guardian Pharmacy Services

105 hedge funds and large institutions have $388M invested in Guardian Pharmacy Services in 2025 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 45 increasing their positions, 15 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,100% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 3

200% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 15

69% more capital invested

Capital invested by funds: $230M → $388M (+$158M)

42% more funds holding

Funds holding: 74105 (+31)

31.83% less ownership

Funds ownership: 111.89%80.06% (-32%)

Holders
105
Holders Change
+31
Holders Change %
+41.89%
% of All Funds
1.38%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
36
Increased
45
Reduced
15
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
JGC
1
J. Goldman & Co
New York
$38M +$21.7M +960,032 +116%
Brown Advisory
2
Brown Advisory
Maryland
$35.9M +$1.8M +79,652 +5%
Wellington Management Group
3
Wellington Management Group
Massachusetts
$23.6M +$14.5M +642,733 +138%
WP
4
Woodline Partners
California
$22.4M +$14.3M +632,175 +150%
Franklin Resources
5
Franklin Resources
California
$20.8M +$5.36M +237,630 +32%
Vanguard Group
6
Vanguard Group
Pennsylvania
$20.6M +$8.59M +380,470 +65%
SAM
7
Silvercrest Asset Management
New York
$19.5M +$20.6M +913,658 New
BlackRock
8
BlackRock
New York
$19.4M +$8.54M +378,254 +71%
TCM
9
TimesSquare Capital Management
New York
$17.4M +$18.4M +814,223 New
Alyeska Investment Group
10
Alyeska Investment Group
Illinois
$16.6M +$7.9M +350,000 +82%
N
11
Nuveen
North Carolina
$11.8M -$11.3M -500,520 -48%
PCM
12
Penn Capital Management
Pennsylvania
$11.4M +$12M +532,787 New
ClearBridge Investments
13
ClearBridge Investments
New York
$9.49M -$1.47M -65,316 -13%
ACB
14
Aristotle Capital Boston
Massachusetts
$8.73M +$9.24M +409,673 New
DCM
15
Driehaus Capital Management
Illinois
$8.62M +$31.7K +1,406 +0.3%
New York State Common Retirement Fund
16
New York State Common Retirement Fund
New York
$7.48M +$631K +27,967 +9%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$7.18M +$3.02M +133,715 +66%
Citadel Advisors
18
Citadel Advisors
Florida
$6.8M +$7.2M +319,248 New
Lazard Asset Management
19
Lazard Asset Management
New York
$6.32M +$2.33M +103,146 +53%
Allspring Global Investments
20
Allspring Global Investments
North Carolina
$6.09M +$30.2K +1,338 +0.5%
State Street
21
State Street
Massachusetts
$5.55M +$2.74M +121,438 +87%
RA
22
Royce & Associates
New York
$5.45M -$393K -17,422 -6%
PCM
23
Peregrine Capital Management
Minnesota
$4.57M +$854K +37,840 +21%
SGM
24
Seven Grand Managers
New York
$4.26M +$2.26M +100,000 +100%
Boston Partners
25
Boston Partners
Massachusetts
$4.23M +$4.55M +201,829 New

GRDN Hedge Fund Activity: Q2 2025 in Review

105 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Guardian Pharmacy Services (GRDN) for Q2 2025, worth a combined $388M — up 69% from $230M a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new GRDN positions and 3 closed out — a net gain of 33 holders — while 45 added to existing stakes and 15 trimmed.

The largest buyer was J. Goldman & Co, adding an estimated $21.7M. The largest seller was Nuveen, cutting an estimated $11.3M.

  • 105 institutional investors held Guardian Pharmacy Services (GRDN) as of Q2 2025, up from 74 in Q1 2025.
  • Funds reported $388M of Guardian Pharmacy Services stock for Q2 2025, up 69% quarter-over-quarter.
  • 36 funds opened new Guardian Pharmacy Services positions in Q2 2025 and 3 closed out, a net change of +33 holders.
  • The largest Guardian Pharmacy Services buyer in Q2 2025 was J. Goldman & Co, an estimated $21.7M added.
  • The largest Guardian Pharmacy Services seller in Q2 2025 was Nuveen, an estimated $11.3M sold.

Based on aggregated 13F filings for Q2 2025.